Generate a tailored SOP for Dr. Kirsten Lauber. Improve your application with a focused, well-structured draft.
Kirsten Lauber leads a research group focused on Molecular Oncology and Radiobiology, primarily investigating how biological characteristics of specific tumors can optimize radiation therapy. The team at LMU Klinikum collaborates across disciplines, integrating insights from biology, pharmacy, biochemistry, and engineering to enhance treatment methodologies based on tumors' molecular profiles. Their fundamental research is instrumental in tailoring therapies to individual patients, leveraging genetic and epigenetic analysis to discern tumor behavior and identify relevant biomarkers. Lauber’s research encompasses analyzing tumor samples and patient clinical histories to guide innovative therapeutic approaches. Current focuses include utilizing molecular tumor markers for better patient stratification, examining immune system mechanisms related to treatment response, and exploring preventive therapies for adverse reactions to radiation.
Administered by the Faculty of Economics. GRE is NOT required for the standard M.Sc. Economics.